Accendra Health, Inc. (ACH) Stock AnalysisACHStock AnalysisAccendra Health, Inc.

Accendra Health, Inc., formerly Owens & Minor, Inc., is a provider of products, technology, and services for health beyond the hospital for millions of people each year. The Company connects patients, providers, and insurers, delivering solutions for people living with chronic, complex health conditions. It provides delivery of products, including disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. It offers a range of products and services for in-home care and delivery across diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure (CPAP) and bi-level positive airway pressure devices, and patient support services). The Company also provides clinical and administrative support services and related products and supplies. It operates in the Healthcare sector.

Accendra Health Inc is not a good buy right now. The current price is $1.21, and the company has reported a significant decline in revenue, with Q2 revenue down 10.1% year-over-year. Additionally, the RSI is at 34.576, indicating that the stock is oversold, but this does not guarantee a price rebound. The forward P/E ratio is 2.8604, which is low, but the company is facing challenges that could hinder recovery, such as a GAAP net loss of $89.1 million in Q2 2026. The main risk is the ongoing revenue decline and the uncertainty surrounding its recovery, as indicated by the downgrades from analysts.